🇺🇸 FDA
Pipeline program

Placebo to match buloxibutid oral capsules, Buloxibutid

VP-C21-011

Phase 2 small_molecule active

Quick answer

Placebo to match buloxibutid oral capsules, Buloxibutid for idiopathic pulmonary fibrosis is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
idiopathic pulmonary fibrosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials